23 May 2013
Keywords: strong, data, avastin, may, lead, lower, dose
Article | 05 March 2007
Swiss drug major Roche says that a Phase III study investigating its drug Avastin (bevacizumab) in combination with chemotherapy met ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 March 2007
19 March 2007
© 2013 thepharmaletter.com